Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay

Journal of Virological Methods

Volumn 102, Issue 1-2, 2002, Pages 37-51

  Dehée, Axelle ^a   Césaire, Raymond ^b   Désiré, Nathalie ^a   Lézin, Agnès ^b   Bourdonné, Olivier ^b   Béra, Odile ^b   Plumelle, Yves ^b   Smadja, Didier ^b   Nicolas, Jean Claude ^a  

^a HÔPITAL ROTHSCHILD   (France)

^b Centre Hospitalier Et Universitaire De Fort de France   (Martinique)

Author keywords

HTLV I; Real time quantitative PCR; TaqMan

Indexed keywords

VIRUS DNA;

ACCURACY; ARTICLE; BLOOD CELL; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; SYMPTOM; T CELL LEUKEMIA; T CELL LYMPHOMA; VIRUS CARRIER; VIRUS DETECTION; VIRUS ETIOLOGY; VIRUS GENE; VIRUS LOAD; VIRUS TITRATION;

BASE SEQUENCE; CARRIER STATE; DNA, VIRAL; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; LEUKOCYTES, MONONUCLEAR; MOLECULAR SEQUENCE DATA; PARAPARESIS, TROPICAL SPASTIC; POLYMERASE CHAIN REACTION; PROVIRUSES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TAQ POLYMERASE; VIRAL LOAD;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 0036186142     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(01)00445-1     Document Type: Article

References (44)

1. Quantitation of human T-cell lymphotropic virus type 1 proviral load by quantitative competitive polymerase chain reaction
2. Quantitation of HTLV-II proviral copies by competitive polymerase chain reaction in peripheral blood mononuclear cells of Italian injecting drug users, central Africans, and Amerindians
3. Absence of human T-lymphotropic virus type I tax sequences in a population of normal blood donors in the Baltimore, MD/Washington, DC, area: Results from a multicenter study
4. Quantitation of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay
5. HTLV-I provirus in seronegative Chilean patients with tropical spastic paraparesis
6. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis
7. High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis
8. Real time quantitative PCR
9. Adult T-cell leukemia: Antigen in an ATL cell line and detection of antibodies to the antigen in human sera
10. Predictors of level of circulating abnormal lymphocytes among human T-lymphotropic virus type I carriers in Japan
11. Association of HTLV-I antibody profile of asymptomatic carriers with proviral DNA levels of peripheral blood mononuclear cells
12. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I
13. Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: A quantitative polymerase chain reaction study
14. Genomic structure of HTLV (human T-cell leukemia virus): Detection of defective genome and its amplification in MT-2 cells
15. Defective human T-cell leukemia virus in adult T-cell leukemia patients
16. Polymerase chain reaction analysis of defective human T-cell leukemia virus type I proviral genomes in leukemic cells of patients with adult T-cell leukemia
17. Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy
18. HTLV-I-seronegative, genome-positive adult T-cell leukemia: Report of a case
19. TaqMan PCR-based gene dosage assay for predictive testing in individuals from a cancer family with INK4 locus haploinsufficiency
20. Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac
21. The epidemiology of the human T-cell lymphotrophic virus type I and type II: Etiologic role in human disease
22. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection
23. Quantitation of HTLV-I provirus among seropositive blood donors: Relation with antibody profile using synthetic peptides
24. Real-time polymerase chain reaction assay for cell-associated HTLV type I DNA viral load
25. Increased human T lymphotropic virus type-1 (HTLV-1) proviral DNA in peripheral blood mononuclear cells and bronchoalveolar lavage cells from Japanese patients with HTLV-1-associated myelopathy
26. Dependency of antibody titer on provirus load in human T lymphotropic virus type I carriers: An interpretation for the minor population of seronegative carriers
27. Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells
28. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: High proviral load strongly predisposes to HAM/TSP
29. Defective provirus form of human T-cell leukemia virus type I in adult T-cell leukemia/lymphoma: Clinicopathological features
30. HAM/TSP: Global review and WHO diagnostic guidelines
31. HTLV-I associated myelopathy, a new clinical entity
32. Human T cell leukemia virus type I (HTLV-I) molecular genotypes and disease outcome
33. Frequent mutation in pX region of HTLV-1 is observed in HAM/TSP patients, but is not specifically associated with the central nervous system lesions
34. Mutation rates in LTR of HTLV-1 in HAM/TSP patients and the carriers are similarly high to Tax/Rex-coding sequence
35. Human adult T-cell leukemia virus: Complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA
36. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87)
37. Semiquantitative analysis of integrated genomes of human T-lymphotropic virus type I in asymptomatic virus carriers
38. Prospective study of HTLV-I infection in an initially asymptomatic cohort
39. Quantitation of proviral DNA load in human T-cell leukaemia virus type I infections
40. Human T lymphotropic virus (HTLV) type I and II DNA amplification in HTLV-I/II-seropositive blood donors of the French West Indies
41. Clonal expansion of infected cells: A way of life for HTLV-I
42. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease
43. Increased replication of HTLV-I in HTLV-I-associated myelopathy
44. Human T-cell lymphotropic virus type 1 tax among American blood donors